| ²é¿´: 1969 | »Ø¸´: 22 | |||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | |||
[½»Á÷]
ÕâÑùµÄÉó¸åÒâ¼û£¬ÎÒµÄÎÄÕÂÔõô·¢ÄØ£¿
|
|||
|
È¥ÄêÉó¸åÒâ¼û»ØÀ´ÁË£¬µ±Ê±ÎÒ¾ÍÕð¾ªÁË£¬Ò²Óеã»ÒÐÄ¡£¡£¡£¡£¡£ ½ñÄ껹ÊǵÃÊÕʰ£¬Çë´ó¼Ò°ïÎÒ¿´¿´Õâ¸öÉó¸åÒâ¼û. ÎÒÏë¼ÌÐø·¢Õâ¸öµµ´ÎµÄÓеãÎÊÌ⣬·¢µÍÒ»µãµÄÐв»£¿ÏÖÔÚÒ²²»¿ÉÄܲ¹ÊµÑéÁË£¬Ö»ÄÜÔÚд·¨ÉÏÐÞ¸ÄÁË¡£ Dear Dr., Thank you very much for submitting your above-mentioned manuscript for review to ####. After careful consideration, we have decided that your manuscript does not meet one or several of our criteria and must be rejected for publication. Specifically, I agree with the reviewer that the results you present are too preliminary to warrant publication at this stage. Unfortunately, due to the concerns described above, we cannot accept a revised version of your manuscript. I am sorry that we cannot be more positive on this occasion, but hope that you appreciate the reasons for this decision. Yours sincerely, ......................................................................................... Reviewers' comments: Much is needed to be improved for this study before ready for manuscript review. First, as it is written as a methods development, at least one target gene needs to be illustrate. There are no details on methodology either. Throughout the manuscript, there is not description of this gene? There is one published paper on this, another one referred to as submitted to Plos1. What is this gene? It is up to the author to explain, not the reviewer to find out through references. Why only 2 out of 6 used were effective? There is no explanation at all. |
» ²ÂÄãϲ»¶
299Çóµ÷¼Á
ÒѾÓÐ8È˻ظ´
Ò»Ö¾Ô¸±±¾©Àí¹¤´óѧ±¾¿Æ211²ÄÁϹ¤³Ì294Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
300Çóµ÷¼Á£¬²ÄÁÏ¿ÆÑ§Ó¢Ò»Êý¶þ
ÒѾÓÐ8È˻ظ´
ÕÐÊÕÉúÎïѧ/ϸ°ûÉúÎïѧµ÷¼Á
ÒѾÓÐ5È˻ظ´
070305¸ß·Ö×Ó»¯Ñ§ÓëÎïÀí 304·ÖÇóµ÷¼Á
ÒѾÓÐ7È˻ظ´
289Çóµ÷¼Á
ÒѾÓÐ13È˻ظ´
Ò»Ö¾Ô¸¹þ¶û±õ¹¤Òµ´óѧ²ÄÁÏÓ뻯¹¤·½Ïò336·Ö
ÒѾÓÐ9È˻ظ´
081200-11408-276ѧ˶Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
µ÷¼ÁÇóԺУÕÐÊÕ
ÒѾÓÐ5È˻ظ´
µ÷¼Á310
ÒѾÓÐ8È˻ظ´
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
ĿǰһƪSCIÂÛÎÄÕýÔÚÉó¸åÖУ¬µ«ÏÖÔÚ·¢ÏÖÁËÎÄÕÂÖеÄһЩÎÊÌ⣬Ôõô°ì
ÒѾÓÐ41È˻ظ´
Éó¸åÒâ¼û·µ»Ø£¬ÓиöÉó¸åÈËÒªÇó²Î¿¼ËûµÄһƪÎÄÕÂ
ÒѾÓÐ10È˻ظ´
ÎÄÕµÄÉó¸åÒâ¼û£¬´ó¼Ò°ïæ¿´¿´£¡
ÒѾÓÐ6È˻ظ´
Éó¸åÖз¢ÏÖ×÷ÕßһƪÏàËÆ¶È¼«¸ßµÄÎÄÕÂÒѾÔÚÁíÒ»ÆÚ¿¯ÔÚÏߣ¬¸ÃÔõô°ì£¿
ÒѾÓÐ63È˻ظ´
·¢½ð±ÒÇóÖú ÀÏʦÈÃÎÒ°ÑÎÄÕÂÖ±½Ó·¢¸øÉó¸åÈË Óʼþ¸ÃÔõôд
ÒѾÓÐ8È˻ظ´
TalantaÎÄÕ±»¾Ü£¬µ«Çë¸÷λ°ïÎÒ¿´¿´ÕâÑùµÄÉó¸åÒâ¼ûÊÇʲôÒâ˼
ÒѾÓÐ15È˻ظ´
ºÜÓÐȤ£ºµ±Reviewer±ä³ÉÎÄÕµĺÏ×÷Õßʱ£¬ÈçºÎ»Ø¸´ËûµÄÉó¸åÒâ¼û£¿Çë¸ßÈËÖ¸µã£¬Ð»Ð»£¡
ÒѾÓÐ35È˻ظ´
±à¼·¢´íÉó¸åÒâ¼û£¬µ«ÎÄÕÂÎÞ½øÕ¹£¬ÈçºÎ´¦Àí
ÒѾÓÐ9È˻ظ´
ÎÒ¸ø¹úÍâÆÚ¿¯ÎÄÕµÄÉó¸å½á¹ûºÍÉó¸åÒâ¼û
ÒѾÓÐ178È˻ظ´
» ÇÀ½ð±ÒÀ²£¡»ØÌû¾Í¿ÉÒԵõ½:
Î÷°²Õ÷½á»éÅ®ÓÑ
+1/286
ÈýÏ¿´óѧ²ÄÁÏÓ뻯¹¤Ñ§Ôº»·¾³¹¦ÄܲÄÁÏ¿ÎÌâ×éÕÐÉú˶ʿµ÷¼ÁÉú
+1/160
ÎåÒØ´óѧ³ØÕñ¹ú½ÌÊÚÍŶÓ2026Äê´óÁ¿½ÓÊÕ»¯Ñ§»¯¹¤²ÄÁϱ³¾°¿¼ÑÐÉú
+5/105
Ìì½ò¿Æ¼¼´óѧÉúÎïÖʹ¦ÄܲÄÁÏÑо¿ÍÅ¶Ó Ë¶Ê¿ÕÐÉú
+1/93
ɽ¶«½¨Öþ´óѧ £¨ÊÐÕþÓë»·¾³¹¤³ÌѧԺ£©Ë¶Ê¿Ñо¿ÉúÕÐÉúÀ² ¾²µç·ÄË¿ÏËάÓëÑÎË®·ÖÀëÓ¦ÓÃ
+1/88
ÖзÉÔºº½¿Õï®µç³ØÍŶӽÓÊÜ˶ʿÉúµ÷¼Á
+1/74
ÉòÑô¹¤Òµ´óѧ-»·¾³µç»¯Ñ§¼¼ÊõÑо¿ÍŶÓ-ÕÐÊÕ˶ʿÑо¿Éú
+3/54
¸£½¨Ê¦·¶´óѧ»·¾³Óë×ÊԴѧԺ»·¾³µç»¯Ñ§¿ÎÌâ×éÕÐÊÕ2026˶ʿ£¨º¬µ÷¼Á£©
+1/29
Î÷»ª´óѧ²ÄÁÏѧԺ±íÃæ¿ÆÑ§Ó빤³Ì¼¼Êõ¿ÆÑÐÍŶÓ2026ÄêÕÐÊÕÑо¿Éú
+1/14
ÕÐÊÕ2026רҵ´úÂë08¿ªÍ·Ë¶Ê¿Ñо¿Éú
+1/12
ÄϾ©ÁÖÒµ´óѧ-¹ú¼Ò¼¶ÇàÄêÈ˲ÅÍÅ¶Ó ÕÐ2026¼¶²©Ê¿¡¢Ë¶Ê¿£¨ºÏ³É»¯Ñ§¡¢Ö²Îﻯѧ·½Ïò£©
+1/9
ËÕÖݳõ´´¹«Ë¾³ÏƸ»¯Ñ§¹ý³Ì¹¤ÒÕÓëÓ²¼þϵͳ¹¤³Ìʦ
+1/9
¡¾²©Ê¿ÕÐÉú¡¿Î人¿Æ¼¼´óѧÕÐÊÕ²ÄÁÏ¡¢»¯¹¤¡¢»·¾³¡¢Ò±½ðÀà2026Äê¡°ÉêÇë-¿¼ºË¡±ÖƲ©Ê¿Éú
+1/8
³ÏƸ²©Ê¿¿ÆÑÐÈËÔ±£¨ÓлúºÏ³É»¯Ñ§·½Ïò£©
+1/7
½Î÷¿Æ¼¼Ê¦·¶´óѧ ²ÄÁÏÓëÄÜÔ´ÕÐÊÕµ÷¼ÁÑо¿Éú
+1/7
¡î ¡î ÖÐɽ´óѧ¸½ÊôµÚÆßÒ½ÔºÐ¤ÜÆ½à¿ÎÌâ×é³ÏÕзÖ×Óҽѧ·½Ïò˶ʿÉú£¨µ÷¼ÁÉú£© ¡î ¡î
+1/6
»¶Ó¸÷λͬѧÉêÇë²Î¼Ó°ÄÃÅ´óѧ½¡¿µ¿ÆÑ§Ñ§ÔºµÄ2026ÄêÏÄÁîÓª£¬±¨Ãû½ØÖ¹4ÔÂ12ºÅ
+1/4
ÄÏ¿ª´óѧ»·¾³¿ÆÑ§Ó빤³ÌѧԺÍõöνÌÊÚ¿ÎÌâ×éÕÐÊÕÉêÇ뿼ºËÖÆ²©Ê¿Éú
+1/4
½ðÊô²ÄÁÏÏȽøÁ¬½Ó¼¼Êõ
+1/3
Î人·ÄÖ¯´óѧ¹ú¼Ò½ÜÇà¿ÎÌâ×é³ÏÕе÷¼Á˶ʿÑо¿Éú
+1/3
12Â¥2011-03-09 21:14:21
2Â¥2011-03-09 16:09:59
visitor958
ÖÁ×ðľ³æ (ÎÄ̳¾«Ó¢)
- Ó¦Öú: 2283 (½²Ê¦)
- ¹ó±ö: 0.05
- ½ð±Ò: 17310
- Ìû×Ó: 15735
- ÔÚÏß: 2926.6Сʱ
- ³æºÅ: 489254
3Â¥2011-03-09 16:14:09
4Â¥2011-03-09 16:35:48














»Ø¸´´ËÂ¥